ReviewCureus2026
Fluorescence-Guided Surgery for Necrotizing Soft Tissue Infections: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing soft tissue infections are life-threatening infections of soft tissue that are treated with rapid surgical debridement when the diagnosis is suspected. Necrotic tissue is removed until vital tissue is identified, guided by the surgeon's vision and hands. Fluorescence-guided surgery is increasingly popular for assessing tissue perfusion. This surgery may have the potential to improve the diagnosis and treatment of necrotizing soft tissue infections. A systematic review on fluorescence-guided surgery for necrotizing soft tissue infections was conducted according to the PRISMA guidelines and Cochrane methodology. A study protocol was prospectively registered on PROSPERO (registration number: CRD420261348991). A comprehensive search was performed across PubMed, Embase, the Cochrane Library, Scopus, Web of Science, ClinicalTrials.gov, and the WHO Clinical Trials Registry Platform. Furthermore, a bibliographic search of relevant literature was conducted. A total of 2377 records were identified and screened. We identified two case studies, including a total of three patients. Both studies found the technique to be feasible in the surgical debridement of necrotizing soft tissue infections, with no adverse events. The main limitation of this review is the limited literature on fluorescence-guided surgery for necrotizing soft tissue infections identified, with only two case studies included. Both reports showed potential benefits in surgical management; however, further studies are urgently needed. This systematic review found a limited number of studies on indocyanine green (ICG) fluorescence-guided surgery in patients with necrotizing soft tissue infections, and the identified evidence was insufficient to draw firm conclusions. Both reports indicate the method's feasibility, with a potentially greater assessment of tissue perfusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.